Form 4: CME Group Director Receives Stock Grant

Patrick J. Mulchrone, a Director at CME Group Inc., received a grant of fully vested Class A Common Stock as part of the company's annual equity compensation program.

Summary

• Patrick J. Mulchrone, a Director of CME Group Inc., was granted 645 shares of Class A Common Stock on June 25, 2026.
• This grant is part of the company's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.
• The shares are fully vested and not subject to any further vesting conditions.
• Following this transaction, Mulchrone beneficially owns 29,130 shares of common stock, with 25,000 shares held indirectly by his spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine director stock grant and does not contain new financial performance data or strategic shifts.

Positives

• Director compensation through stock grants indicates alignment of management interests with shareholders.
• The grant of fully vested shares provides immediate benefit to the director.
• CME Group continues its practice of rewarding directors through its established stock plan.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's stock grant.

Industry Context

StockSavvy.ai notes that equity compensation for directors is a common practice in the financial services and exchange industry, aimed at aligning director interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The stock grant reinforces director alignment with shareholder interests, potentially contributing to long-term value creation.
• Employees: This filing does not directly impact employees, but it reflects the company's compensation practices for its board members.

Key Dates

Keywords

CME Group, Form 4, Stock Grant, Director Compensation, Equity Compensation, Beneficial Ownership, SEC Filing